B+
Bull case
20%
Probability
Target price
$12.12
+639.0% vs current
ALDX
Aldeyra TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$9.25
+464.0% vs current
B-
Bear case
20%
Probability
Target price
$4.99
+204.3% vs current
AI sentiment snapshot
Latest data as of 2026-02-27
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Analyst consensus sits materially above the broker_last anchor, implying upside if clinical/regulatory news is positive. Coverage dispersion and binary event risk keep sentiment conditional and prone to episodic volatility.
RankAlpha Sentiment AI - 2026-02-27
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
No AI events listed.
View full catalyst timelineRecommendation
N/A
No formal recommendation provided.
As of 2026-02-27 • Updated nightlySource: Internal modelMethodology